Understanding how MRSA affects lung function and causes injury
Pathobiology of MRSA-induced Endothelial Permeability and Acute Lung Injury
This study is looking at how a tough bacteria called MRSA can harm the lungs and cause serious breathing problems, and it’s testing new treatments that might help protect lung cells and improve recovery for people with these issues.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Illinois at Chicago NIH-funded |
| Lab location | 1 site (Chicago, UNITED STATES) |
| Project ID | NIH-10984487 on NIH RePORTER |
What this research studies
This research investigates the mechanisms by which methicillin-resistant Staphylococcus aureus (MRSA) contributes to acute lung injury and acute respiratory distress syndrome (ARDS). The study focuses on the dysfunction of vascular endothelial cells, which play a critical role in maintaining lung health. By exploring the effects of novel compounds that enhance endothelial barrier function, the research aims to identify potential therapeutic targets for improving outcomes in patients suffering from ARDS caused by sepsis. The approach includes preclinical models to assess the efficacy of these compounds in restoring normal lung function.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults diagnosed with ARDS, particularly those with sepsis caused by MRSA.
Not a fit: Patients with ARDS not related to MRSA or sepsis may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that improve lung function and survival rates for patients with ARDS.
How similar studies have performed: Previous research has shown promise in targeting endothelial dysfunction in ARDS, but this specific approach using novel compounds is relatively novel.
Where this research is happening
Chicago, UNITED STATES
- University of Illinois at Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Dudek, Steven M — University of Illinois at Chicago
- Study coordinator: Dudek, Steven M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.